Original Research

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey

Petrella RJ, Tremblay G, De Backer G, Gill DP

Vascular Health and Risk Management 2014, 10:63-74

Published Date: 29 January 2014